glycemic control

About Topics

Topics include original Beta Cells in Diabetes content, as well as expert-selected resources chosen by our Editorial Board.

Hyperglycemia in Patient on Basal-Bolus Insulin

A 58-year-old Caucasian female presents to your office for a recheck. She has had type 2 diabetes mellitus (T2DM) for 16 years and has a history of hypertension, dyslipidemia, and obesity, with minimal diabetic retinopathy and albuminuria. Despite active titration of her insulin, she continues to have consistent hyperglycemia.

Sleep Apnea in Patients with Type 2 Diabetes

Obstructive sleep apnea is a common and underdiagnosed condition in patients with type 2 diabetes. This blog post explores what is known about the underlying mechanism that may relate sleep apnea to diabetes.

One-year sustained glycemic control and weight reduction in type 2 diabetes after addition of liraglutide to metformin followed by insulin detemir according to HbA1c target.

Rosenstock, Julio; Rodbard, Helena W; Bain, Stephen C; D'Alessio, David; Seufert, Jochen; Thomsen, Anne B; Svendsen, Claus Bo; DeVries, J Hans
Journal of diabetes and its complications; 27(5):492-500. PMID: 23746555;
Category: Interventions;

Incretins and Questions About the Pancreas

 
Over the past six months we have had more questions than answers about the risk of incretin therapy (DPP-4 inhibitors and GLP-1 agonists) and the increased risks for both pancreatitis and pancreatic carcinoma.

Initial Combination Therapy in a Newly Diagnosed Patient

Doron Schneider, MD and Jack Leahy, MD discuss the treatment option of initial combination therapy in a newly diagnosed T2DM patient. 

Listen to the podcast or read the transcript.

Shared Decision Making

With all the things I have to cover during my 20 minute follow-up visits with my patients with diabetes, I sometimes struggle with whether or not to interrupt as they tell me about something that, at first, seems irrelevant, at least to me.

Considering CAD Risk Factors in Treatment Decisions

 Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options. 

Considering CAD Risk Factors in Treatment Decisions

Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options.  (12:08)

Initial Combination Therapy in a Newly Diagnosed T2DM Patient

Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)

PODCAST: Treatment Options for a Young, Newly Diagnosed Patient with a High BMI

Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD. (50:19)

  • Page 1 of 12
  •  
  • Next
|